Published in Cardiovascular Device Liability Week, April 25th, 2004
The shares are being offered under the company's effective shelf registration statement previously filed with the Securities and Exchange Commission. Rodman & Renshaw, LLC, acted as placement agent for the offering.
The proceeds of the financing will be used for research and product development activities, as well as for general corporate purposes.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.